A retrospective evaluation of clotting factor concentrate usage for the periprocedural management of patients with hemophilia A before and after the introduction of emicizumab
A retrospective evaluation of clotting factor concentrate usage for the periprocedural management of patients with hemophilia A before and after the introduction of emicizumab. // Thrombosis Update. – URL: https://www.sciencedirect.com/science/article/pii/S2666572726000271?dgcid=rss_sd_all
A retrospective evaluation of clotting factor concentrate usage for the periprocedural management of patients with hemophilia A before and after the introduction of emicizumab. Thrombosis Update. https://www.sciencedirect.com/science/article/pii/S2666572726000271?dgcid=rss_sd_all
“A retrospective evaluation of clotting factor concentrate usage for the periprocedural management of patients with hemophilia A before and after the introduction of emicizumab.” Thrombosis Update.
@article{article69483,
title = {A retrospective evaluation of clotting factor concentrate usage for the periprocedural management of patients with hemophilia A before and after the introduction of emicizumab},
journal = {Thrombosis Update},
url = {https://www.sciencedirect.com/science/article/pii/S2666572726000271?dgcid=rss_sd_all}
}